Furthermore, we explored the disparities in CSPG4 expression between BLCA and normal tissues, alongside an assessment of CSPG4's prognostic significance in patients with BLCA, substantiated through immunohistochemistry and clinical patient data. Here, CSPG4 is linked to bladder transitional cell carcinoma.